Chemical Component Summary

Name6-[(1~{R})-1-[8-fluoranyl-6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]-3-(2-methoxyethoxy)-1,6-naphthyridin-5-one
Identifiers6-[(1~{R})-1-[8-fluoranyl-6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]-3-(2-methoxyethoxy)-1,6-naphthyridin-5-one
FormulaC23 H22 F N7 O3
Molecular Weight463.464
TypeNON-POLYMER
Isomeric SMILESC[C@H](c1nnc2n1cc(cc2F)c3cnn(c3)C)N4C=Cc5c(cc(cn5)OCCOC)C4=O
InChIInChI=1S/C23H22FN7O3/c1-14(30-5-4-20-18(23(30)32)9-17(11-25-20)34-7-6-33-3)21-27-28-22-19(24)8-15(13-31(21)22)16-10-26-29(2)12-16/h4-5,8-14H,6-7H2,1-3H3/t14-/m1/s1
InChIKeyDWHXUGDWKAIASB-CQSZACIVSA-N

Chemical Details

Formal Charge0
Atom Count56
Chiral Atom Count1
Bond Count60
Aromatic Bond Count21

Drug Info: DrugBank

DrugBank IDDB15639 
NameAMG-337
Groups investigational
DescriptionAMG-337 is under investigation in clinical trial NCT03147976 (QUILT-3.036: AMG 337 in Subjects With Advanced or Metastatic Solid Tumors).
SynonymsAMG-337
Categories
  • Antineoplastic Agents
  • Pyridines
CAS number1173699-31-4

Related Resource References

Resource NameReference
Pharos CHEMBL3785909
PubChem 44181686
ChEMBL CHEMBL3785909